Description
| What It Is | Cagrilintide is a long-acting synthetic analogue of the endogenous hormone amylin and functions as a dual amylin and calcitonin receptor agonist in research settings. |
| What It’s Derived From | It is derived from human amylin, a peptide hormone co-secreted with insulin by pancreatic beta cells, and chemically modified to extend its half-life and receptor activity. |
| What Research Focuses On | Research evaluates Cagrilintide in preclinical and clinical models examining amylin receptor signaling, gastric motility pathways, neuroendocrine regulation of appetite, and metabolic signaling mechanisms under controlled conditions. Studies also explore receptor interaction dynamics when evaluated alongside incretin-related pathways. |
Reviews
There are no reviews yet.